Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track MENS with free AI briefings, catalyst countdowns, and dilution alerts.

MENS · Jyong Biotech Ltd.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$1.2M Cash on Hand
4.6mo Cash Runway
Follow MENS by email Get an email when MENS reports key news in an SEC filing, pushes back a promised milestone, files for a stock offering, lands on the Downside Radar or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about MENS, unsubscribe in one click. Privacy

💰 Cash Runway & Dilution Risk

MENS holds $1.2M in cash and short-term investments and burns about $760,250/quarter from operations, an estimated runway of 4.6 months at that rate (BioRadar estimate, not company guidance).

Dilution pressure: 55 · Elevated

Recent financing filings on SEC EDGAR:

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when MENS files for a raise →

👥 Who Owns MENS

Insiders 33.4% Other 5%+ holders 33.3% Institutions (23 holders) 0.7% Public and other holders 32.6%
HolderTypeShares% of sharesAs of
Fu-feng Kuo
CEO, Director, 10% owner
Insider 25,349,500 33.34% 2026-04-08
Perfect Minds Co., Ltd 5%+ holder (13D) 25,349,500 33.34% 2025-06-16
Feng-Lin Hsu
Director
Insider 3,000 0.00% 2026-04-01
Ming Tsan Hsu
Director
Insider 3,000 0.00% 2026-04-01

Share count 76,027,667 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the total held by all 13F filers (Yahoo Finance); the table lists the largest. Sources have different dates, so the split is approximate. Source: SEC EDGAR.

Get the full MENS picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for MENS and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.